Literature DB >> 270626

Erythromycin: clinical review I. Clinical pharmacology.

P Nicholas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 270626

Source DB:  PubMed          Journal:  N Y State J Med        ISSN： 0028-7628


× No keyword cloud information.
  5 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Neonatal campylobacter enteritis.

Authors:  M A Karmali; Y C Tan
Journal:  Can Med Assoc J       Date:  1980-01-26       Impact factor: 8.262

3.  Plasma and sputum erythromycin concentrations in chronic bronchitis.

Authors:  G E Marlin; P R Davis; J Rutland; N Berend
Journal:  Thorax       Date:  1980-06       Impact factor: 9.139

4.  Influence of food on absorption of erythromycin ethyl succinate.

Authors:  P J Thompson; K R Burgess; G E Marlin
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

5.  In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.

Authors:  C A Benson; J Segreti; F E Beaudette; D W Hines; L J Goodman; R L Kaplan; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.